Toxic Inhalational Lung Injury

Published on 23/05/2015 by admin

Filed under Pulmolory and Respiratory

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2325 times

Chapter 56 Toxic Inhalational Lung Injury

A variety of chemicals, when liberated into the atmosphere as gases, fumes, or mist, can cause irritant lung injury or asphyxiation. As summarized in Table 56-1, any level of the respiratory tract can be the target for toxins, which produce a wide range of disorders, from tracheitis and bronchitis to pulmonary edema.

Table 56-1 Inhalational Toxins and Range of Toxicity

Toxins Effects
Ammonia Mucous membrane irritation and sloughing
Bronchiectasis, pulmonary interstitial fibrosis
Ammonia, phosgene, hydrogen sulfide Laryngeal edema and obstruction
Carbon monoxide, cyanide, hydrogen sulfide Asphyxiation
Chlorine, phosgene Acute respiratory distress syndrome
Hydrofluoric acid Systemic effects, hypocalcemia, hypomagnesemia
Hydrogen chloride, chlorine Tracheobronchitis
Hydrogen fluoride, mustard gas Chemical pneumonitis
Hydrogen sulfide Bacterial pneumonia
Nitric oxide Systemic effects, methemoglobinemia
Oxides of nitrogen, sulfur oxides Obliterative bronchiolitis (bronchiolitis obliterans)
Sulfur dioxide, hydrogen chloride, oxides of nitrogen, ozone Bronchoconstriction, airway edema, asthma

Etiology and Risk Factors

Major risk factors for inhalational exposure and injury are related to the environment and not to the individual. Exposures occur randomly in the general environment, such as when a chemical spill occurs on a highway or railroad, carbon monoxide (CO) leaks in a home, or a person incorrectly mixes household chemicals together and releases a gas or aerosol. Smoke that comprises the pyrolysis products of synthetic materials is a common cause of injury to the respiratory tract, as well as a cause of pulmonary insufficiency and death from fires.

Occupational injuries more often occur when workers handle chemicals, work in areas that are inadequately ventilated, or enter exposed areas with improper protective equipment. Table 56-2 lists sources of occupational exposure to major chemical causes of irritant lung injury and asphyxiation.

Table 56-2 Inhalational Toxins and Source of Exposure

Toxin Sources of Exposure
Ammonia Agriculture, explosives, plastics
Carbon monoxide Firefighters, smoke inhalation, smelters, miners, transportation, home furnaces
Chlorine Household cleaners, paper, textiles, sewage treatment, swimming pools
Hydrofluoric acid Fertilizers, insecticides, glass and ceramic etching, masonry, metalworking, pharmaceuticals, chemical manufacture
Hydrogen chloride Fertilizers, textiles, dyes, rubber manufacture
Hydrogen cyanide Metallurgy, electroplating, plastics, polyurethane manufacture
Hydrogen sulfide Metallurgy, chemical manufacture, wastewater treatment, natural gas and oil drilling, paper mills, coke ovens, rayon manufacture, rubber vulcanization
Mustard gas Chemical warfare
Oxides of nitrogen Air pollution, welding, hockey rinks, chemical and dye manufacture, agriculture
Ozone Welding, air pollution, high altitude, chemical manufacture
Phosgene Firefighters; paint strippers; chemical, pharmaceutical, and dye manufacturing; chemical warfare
Sulfur dioxide Air pollution, smelting, power plants, chemical manufacture, paper manufacture, food preparation

Factors that influence the acute effects of toxic chemicals include solubility, particle size, concentration, duration of exposure, chemical properties, and individual factors such as minute ventilation. The more water-soluble compounds dissolve in the upper respiratory tract and airways, whereas the less water-soluble agents tend to bypass the upper airway and affect peripheral airways and pulmonary parenchyma (Figure 56-1).

Pathology

In general, the upper airway can be affected by most inhaled toxins, which result in edema of the nasal passage, posterior oropharynx, and larynx. In severe cases, mucous membrane ulceration and hemorrhage ensue. Toxins of low water solubility may reach the lung parenchyma without necessarily producing upper airway lesions. If breath holding, laryngospasm, and normal “scrubbing” activities of the nasopharynx fail to contain the exposure, lesions develop in the trachea and bronchi (e.g., paralysis of cilia, increased mucus production, goblet cell hyperplasia, injury to airway epithelium, epithelial denudation, exudation, submucosal hemorrhage, edema). Pseudomembranes may form along the trachea and bronchi, causing various degrees of bronchiolitis, bronchiolitis obliterans (Figure 56-2), and organizing pneumonia (Figure 56-3). Bronchiolitis has been associated with exposures to oxides of nitrogen—nitric oxide (NO), nitrogen dioxide (NO2), and nitrogen peroxide (N2O4)—as well as sulfur dioxide, ammonia, chlorine (Cl2), phosgene, fly ash that contains trichloroethylene (C2HCl3), ozone (O3), hydrogen sulfide, hydrogen fluoride (HF), metal oxide fumes, dusts (e.g., asbestos, silica, talc, grain dust), free-base cocaine, tobacco smoke, and fire smoke.

Parenchymal injury is less common than airway damage. When alveolar or interstitial injury occurs, both epithelial damage and endothelial damage are observed, resulting in alveolocapillary leak and the pathologic changes of adult respiratory distress syndrome (ARDS). Diffuse alveolar damage (DAD) is a common histologic pattern in acute interstitial lung disease caused by inhaled toxins. It is characterized by widespread, diffuse edema, epithelial necrosis and cell sloughing (with exudates that fill the alveolar spaces), and formation of hyaline membranes (Figure 56-4). Later, DAD may organize, which leads to proliferation of type II pneumonocytes, resorption of the hyaline membranes and exudates, and fibroblast proliferation. Long-term survivors of such parenchymal injury may fully recover or may have various degrees of permanent interstitial fibrosis.

Clinical Features and Diagnosis

Diagnosis should focus on the nature of the compound inhaled, the magnitude and duration of exposure, and the water solubility of the inhaled agent. Inhalational injury is suspected in those who have facial burns or inflamed nares. Headache and dizziness, along with chest pains and emesis, suggest systemic poisons (e.g., cyanide, H2S). Unconscious victims found in confined spaces are assumed to have received longer inhalational exposures than conscious ones because of the unprotected airways and concentrated exposures. Evidence of hoarseness, upper airway stridor, wheezing or rales, cough, and sputum production is assessed. Chest radiographs may show pulmonary edema, atelectasis, or infiltrates (Figure 56-5), although they are often negative early after exposure. Flow-volume loops are the most sensitive noninvasive indicators of upper and lower airway obstruction. Hypoxemia in the face of a normal arterial partial pressure of oxygen (PaO2) suggests CO toxicity. Carboxyhemoglobin levels are obtained for all fire and explosion victims. Metabolic acidosis may indicate cyanide or H2S intoxication.

In patients who have persistent symptoms months after exposure, bronchial provocation tests with methacholine may help assess whether the patient has reactive airway dysfunction syndrome. Computed tomography (CT) may help determine if permanent fibrotic changes have developed.

Chemical Irritants

Sulfur Dioxide

Sulfur dioxide and sulfuric acid (H2SO4) aerosols are produced by fossil fuel combustion. These toxic gases are encountered in power plants and in various industrial processes, such as smelting, chemical manufacture, paper manufacture, food preservation, metal and ore refining, and refrigeration. Past SO2 air pollution catastrophes have increased mortality rates for patients with chronic lung disease and elderly patients.

As little as 0.5 ppm of SO2 can be detected in air from its characteristic odor. Levels of 6 to 10 ppm may immediately irritate eyes and the nasopharynx. High exposures (≥50 ppm) injure the larynx, trachea, bronchi, and alveoli. A wide range of individual variability in the response to SO2 is found, but atopic and asthmatic patients show the most susceptibility. Prior exposure to ozone may potentiate the effect of SO2 in asthmatic subjects. Classically, patients first experience a burning of the eyes, nose, and throat, with associated cough, chest pain, chest tightness, and dyspnea, along with conjunctivitis, corneal burns, and pharyngeal edema, followed hours later by pulmonary edema. Obliterative bronchiolitis (OB; bronchiolitis obliterans) can develop 2 to 3 weeks after exposure. Persistent airflow obstruction has been observed in smelter workers up to 4 years after SO2 overexposure, probably because of bronchiolitis obliterans.

Symptomatic treatment for acute SO2 toxicity may include systemic corticosteroids. Bronchospasm in asthmatic patients may reverse spontaneously after removal from SO2 exposure, or may require administration of bronchodilators and inhaled corticosteroids.

Oxides of Nitrogen

The oxides of nitrogen (NO, NO2, N2O4) can produce fatal respiratory injury for some of the millions of workers who come into contact with these gases. Occupations at risk include coal miners after firing of explosives, welders who work with acetylene torches in confined spaces, hockey rink workers, and chemical workers exposed to by-product fumes in the manufacture of dyes, lacquers, and nitric acid (HNO3). Silo filler’s lung (silo filler’s disease) occurs with inhalation of NO2 formed from fermented corn or alfalfa in silos. The greatest risk occurs in the first few weeks after filling the silo. Because the oxides of nitrogen have low water solubility, the lower respiratory tract can be exposed to these potent oxidizers. NO2 reacts with H2O in the lung to form nitric and nitrous (HNO2) acids. The oxides dissociate into O2 free radicals, nitrates, and nitrites, which cause tissue inflammation, lipid peroxidation, and impairment of surfactant activity (among other cellular changes). Notably, nitric oxide has a high affinity for hemoglobin and thus causes methemoglobinemia.

With oxides of nitrogen, exposures of 15 to 25 ppm result in acute mucous membrane irritation of the eyes and throat. At exposure levels of 25 to 100 ppm, toxic pneumonitis and bronchiolitis can develop, often with a smothering sensation and dyspnea. Exposures above 150 ppm are often fatal, associated with OB, chemical pneumonitis, and pulmonary edema. Symptom onset may be delayed, and patients are cautioned that relapses can occur 3 to 6 weeks after initial exposure, with symptoms of cough, chills, fever, and shortness of breath. In some, persistent obstructive lung disease and chronic bronchitis develop. Case reports suggest improvement after corticosteroids in patients exposed to oxides of nitrogen who manifest bronchiolar inflammation.

Chemical Asphyxiants

Nitrous oxide, carbon monoxide, hydrogen cyanide (HCN), and hydrogen sulfide interfere with oxygen delivery, which results in asphyxiation. Others, such as methane, ethane (C2H6), argon (Ar), and helium (He2), are more innocuous at low concentrations, but at high exposure levels can displace oxygen or block the reaction of cytochrome oxidase or hemoglobin, impairing cellular respiratory and O2 transport. Several important asphyxiants are discussed in the following sections.

Carbon Monoxide

Carbon monoxide is colorless, tasteless, and odorless, and is the major cause of death by poisoning in the United States and most industrialized countries. Exposure results from incomplete combustion of carbon-containing materials such as gasoline, coal, and wood. Home CO exposures occur from furnace gas leaks or fire smoke inhalation. Methylene chloride (CH2Cl2), used in paint strippers and household solvents, metabolizes into CO and can be deadly if handled in poorly ventilated areas.

Severe forms of CO poisoning are characterized by unconsciousness, seizures, syncope, coma, neurologic deficits, pulmonary edema, myocardial ischemia, and metabolic acidosis. Lower exposures produce symptoms of headache, nausea, weakness, giddiness, and tinnitus. Confusion typically occurs at carboxyhemoglobin levels greater than 30%, with coma ensuing at 35% to 45%, and death at 50%. Affected individuals are at risk for delayed neuropsychological effects. Carboxyhemoglobin levels correlate poorly with the clinical severity of neurologic sequelae. CO half-life in individuals at rest is approximately 4 hours and can be reduced to 60 to 90 minutes by breathing 100% O2 by face mask or to less than 60 minutes with O2 administered by manual bag-assisted ventilation.

Nonrandomized studies show that hyperbaric oxygen reverses the acute effects of CO poisoning and is the most rapid means of reversing acute toxicity. Additional treatments may improve acute neurologic defects. Results of controlled trials are unclear as to the efficacy of hyperbaric oxygen as a treatment for the delayed neuropsychological symptoms. Cardiac monitoring is warranted for patients who have carboxyhemoglobin levels greater than 25% because of the risk of arrhythmias and myocardial infarction.

Hydrogen Sulfide

Hydrogen sulfide is both a respiratory irritant and asphyxiant. As a colorless, naturally occurring gas, H2S is found in marshes and sulfur springs and as a decay product of organic matter. It is known for its typical “rotten egg” odor. Occupational exposure occurs in the manufacture of chemicals and metals, in petroleum refineries, natural gas plants, coke ovens, paper mills, rubber vulcanization, rayon manufacture, and in tanneries. Heavier than air, H2S accumulates in low-lying areas; it causes poisoning during oil drilling, wastewater treatment, and natural-gas field leaks. The H2S reaction with metalloenzymes, such as cytochrome oxidase, accounts for much of its toxicity in humans.

The odor threshold for H2S is low (0.13 ppm). At concentrations of 50 ppm, H2S is a mucous membrane irritant. Above 100 ppm, the gas fatigues the sense of olfaction, which makes individuals insensitive to its continued presence. When inhaled, H2S preferentially affects the lower respiratory tract. At concentrations of 250 ppm, pulmonary edema can occur. At 500 ppm, systemic and neurologic effects develop, with sudden loss of consciousness seen above 700 ppm. Above 1000 ppm, H2S produces hyperpnea and apnea, which paralyze respiratory drive centers, resulting in death by asphyxia. Prolonged low-level (50 ppm) exposures can cause respiratory tract inflammation and drying; typical symptoms of cough, sore throat, hoarseness, rhinitis, and chest tightness occur between 50 and 250 ppm. At higher acute exposure levels, such symptoms may not manifest because of the rapid absorption of the gas through the lung into the bloodstream.

Management of the patient with H2S poisoning is generally supportive, with prompt endotracheal intubation and mechanical ventilation for severe cases of intoxication. Oxygen enhances sulfide metabolism and benefits hypoxic tissue. Because the mechanism of H2S toxicity is similar to that of cyanide, induction of methemoglobinemia with infusion of 3% sodium nitrite or inhalation of amyl nitrate is recommended. Hyperbaric oxygen therapy may be beneficial.

Metals

Inflammatory and Autoimmune Agents

Biochemical Toxins and Weaponized Agents

A variety of agents have been developed and used to cause mass injury or disruption. Table 56-3 provides an overview of pulmonary effects and treatment of these toxicities. With all chemical exposures, individuals should be removed from exposure and given supportive care.

Table 56-3 Categories of Biochemical Poisons and Weapons: Specific Agents, Pulmonary Effects, and Treatment

Toxin Pulmonary Effect Treatment
Biotoxins/Poisoning Agents
Ricin (phytotoxin) Cough, pulmonary edema Pulmonary toilet, oxygen, mechanical ventilation, cardiopulmonary resuscitation
Blister Agents/Vesicants
Lewisite Respiratory tract irritation, coryza sneezing, hoarseness, epistaxis, dyspnea and cough, pneumonitis, pulmonary edema, respiratory failure Dimercaprol (antilewisite, British anti-lewisite [BAL])
Lung-Damaging Agents
Chloropicrin Coughing, dyspnea, chest tightness, pulmonary edema β2-Adrenergic agonists and corticosteroids for bronchospasm
Nerve Agents
Sarin, Soman, Tabun, VX Respiratory failure Atropine, 2-PAM (pralidoxime); benzodiazepines for convulsions
Riot Control/Tearing Agents
Chloroacetophenone Rhinorrhea, cough, sneezing, chest tightness, dyspnea, pulmonary edema, bronchospasm  
Vomiting Agents
Adamsite (diphenylamine chlorarsine) Rhinorrhea, cough, sneezing Oxygen; bronchodilators for bronchospasm

Complex Exposures

In practice, patients with inhalational injuries are frequently exposed to complex mixtures of toxic compounds rather than a single agent. Such admixtures may be poorly characterized, and may contain combustion products, pyrolysis products, metals, particulates, and gas. Recent studies illustrate the ability of such mixtures to produce a range of airway and diffuse interstitial lung lesions.

As a consequence of exposures immediately after the World Trade Center collapse in 2001, pulmonary function decline, reactive airways dysfunction syndrome (RADS), asthma, reactive upper airways dysfunction syndrome (RUDS), sinus complaints, gastroesophageal reflux disease (GERD), and cases of inflammatory pulmonary parenchymal diseases (e.g., sarcoidosis) have been documented among rescue and recovery workers and volunteers. Specifically, in rescue workers with a high level of exposure, 8% experienced new onset of cough, 95% had symptoms of dyspnea, 87% had GERD, 54% had nasal congestion, and 23% of workers were identified as having bronchial hyperreactivity 6 months later. About 16% of rescue workers met the diagnosis criteria for RADS 1 year after the collapse. In a longitudinal study of pulmonary function in rescue workers before and after exposure, the average adjusted FEV1 decreased 372 mL during the year after September 2001, which translates to an estimated 12 years of aging-related FEV1 decline.

Factors such as dust alkalinity may have contributed to some of these conditions, although as often the case in acute situations, detailed information about the inhalational exposures in those workers is limited. Detailed qualitative and quantitative analyses of airborne pollutants with their changing composition during initial rescue/recovery and subsequent cleanup have been published, but incomplete air quality monitoring during and early after the structural collapse make full individual assessment of this exposure problematic.

Controversies and Pitfalls

Many of the uncertainties in this arena of pulmonary medicine pertain to the management and treatment of inhalational injury, for which a few general comments apply. In patients with severe inhalational injury, intubation may be required for airway protection. Careful observation, preferably in an intensive care setting, is recommended for suspected cases of significant inhalational injury. Some advocate direct laryngoscopy or fiberoptic bronchoscopy to assess for laryngeal edema. However, no clear guidelines are available to direct clinicians as to when intubation, laryngoscopy, or bronchoscopy is warranted. Although many clinicians may empirically prescribe corticosteroids, such medications have not been proved efficacious for many of the conditions described. Designing randomized controlled trials to treat sporadic acute inhalational injuries is difficult.

A common clinical pitfall is to dismiss prematurely patients who may be at risk for delayed-onset respiratory disorders such as asthma, OB (bronchiolitis obliterans), chemical pneumonitis, or pulmonary edema. Given sufficient dose and solubility, most acutely inhaled substances pose a risk for immediate or delayed-onset pulmonary edema, which warrants careful observation. Even those toxin victims who are thought to be stable and ready for discharge from the emergency department must be given detailed instructions about the warning signs of delayed-onset respiratory tract injury.

Routine spirometry in groups considered at high risk for acute inhalational exposures may be warranted, based on the exposures of New York City firefighter and rescue worker clinics.